Clinical Trial Update: Exploratory Study to Assess the Efficacy and Safety of TC-5214 in the Treatment of Subjects With Palmar Hyperhidrosis [Phase 2]

View source ↗

Summary

Phase 2 exploratory study assessing the efficacy and safety of TC-5214 for palmar hyperhidrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Palmar Hyperhidrosis

Drugs mentioned

• TC-5214 (TC-5214)

Snippet

Sponsor: Atacama Therapeutics | Conditions: Palmar Hyperhidrosis | Phase 2 | Status: COMPLETED